title: Rhinovirus and coronavirus infections.
abstract: Rhinoviruses and coronaviruses cause the majority of common colds and play a part in more serious respiratory illnesses that lead to increased morbidity and mortality. Patients who are infants or elderly, have asthma or chronic obstructive pulmonary disease (COPD), or are immunosuppressed have increased frequency of rhinovirus-related respiratory complications. Newer diagnostic tests such as reverse transcriptase polymerase chain reaction (RT-PCR) have greatly expanded our understanding of the importance of these respiratory viruses. Although there are no currently approved antiviral agents for clinical use, our increased understanding of the virus-host interaction should lead to new intervention strategies.
authors: Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA. stepheng@bcm.edu
authors: Stephen B
authors: SB
authors: Greenberg
mesh_terms: D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use; D001249:Asthma / Q000150:complications; D003139:Common Cold / Q000150:complications / Q000188:drug therapy; D017934:Coronavirus / Q000235:genetics; D018352:Coronavirus Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D003550:Cystic Fibrosis / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host; D010033:Otitis Media / Q000150:complications; D010850:Picornaviridae Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012229:Rhinovirus / Q000235:genetics; D012852:Sinusitis / Q000150:complications
chemical_list: D000998:Antiviral Agents